Kurum Yazarı "Turgut, Burhan" Tıp Fakültesi Koleksiyonu İçin Listeleme
-
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
Yigenoğlu, Tuğçe Nur; Başçı, Semih; Şahin, Derya; Ulaş, Turgay; Dal, Mehmet Sinan; Korkmaz, Serdal; Altuntaş, Fevzi; Turgut, Burhan (Pergamon-Elsevier Science Ltd, 2021)SARS-CoV-2 attaches to the angiotensin-converting enzyme 2 (ACE-2) receptor on human cells. The virus causes hypercytokinemia, capillary leak, pulmonary edema, acute respiratory distress syndrome, acute cardiac injury, and ... -
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Çekdemir, Demet; Güvenç, Serkan; Özdemirkıran, Füsun; Eser, Ali; Topts, Tayfur; Özkocaman, Vildan; Küçükkaya, Reyhan Diz; Tekinalp, Atakan; Turgut, Burhan (Galenos Yayincilik, 2019)Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total ... -
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Başcı, Semih; Ata, Naim; Altuntaş, Fevzi; Yigenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Sage Publications Ltd, 2020)Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ... -
The outcome of COVID-19 in patients with hematological malignancy
Yigenoğlu, Tuğçe Nur; Ata, Naim; Altuntaş, Fevzi; Başçı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Wiley, 2021)In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 ... -
The outcome of COVID-19 in patients with hematological malignancy (Letter)
Yigenoğlu, Tuğçe Nur; Başçı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Turgut, Burhan; Altuntaş, Fevzi (Wiley, 2021)[No Abstract Available] -
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Başcı, Semih; Ata, Naim; Altuntaş, Fevzi; Yigenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Springer-Verlag Italia Srl, 2022)Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course ... -
A rare retrograde intrarenal surgery complication: Hemophagocytic syndrome
Akgül, Murat; Yazıcı, Cenk Murat; Ateş, Hüseyin; Altın, Enes; Turgut, Burhan (Mary Ann Liebert Inc., 2020)Background: Hemophagocytic syndrome (HS) is a syndromic complex that is categorized in the group of histiocytic disorders associated with macrophages. Case Presentation: A 39-year-old male patient was admitted to the ... -
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
Akpınar, Seval; Doğu, Mehmet Hilmi; Çelik, Serhat; Ekinci, Ömer; Yönal Hindilerden, İpek; Dal, Mehmet Sinan; Altuntaş, Fevzi; Turgut, Burhan (Elsevier Inc., 2022)Introduction/Background: The emergence of novel agents targeting the B-cell receptor pathway and BCL-2 has significantly changed the therapeutic landscape of CLL. We evaluated the safety and efficacy of single-agent ibrutinib ... -
Relaps/Refrakter Lenfoma (Mantle Hücreli Lenfoma Hariç) Hastalarında Lenalidomid Bazlı Tedavi Sonuçları: Çok Merkezli Sonuçlar
Amaç: Lenfomalar, çoğunlukla B hücre kökenli heterojen bir hastalık grubunu temsil eder. Lenalidomid, kemo-immünoterapötik ajanlara talidomidin yapısal bir analoğu olarak dahil edilmiştir. Bu çalışmada amaç, mantle hücreli ... -
The role of oxidized phospholipids in COVID-19-associated hypercoagulopathy
Akpınar, Seval; Oran, Mustafa; Doğan, Mustafa; Çelikkol, Aliye; Erdem, İlknur; Turgut, Burhan (Verduci Editore s.r.l, 2021)OBJECTIVE: There is more pronounced hypercoagulation in COVID-19 infection than in other viral lung infections. Oxidized phospholipids (OxPLs) appear in COVID-19-infected lungs due to oxidative stress, after which they ... -
Severe Immune Thrombocytopenia in Pregnancy Treated with Eltrombopag. A Case Report.
Immune Thrombocytopenia (ITP) which is a common, acquired and autoimmune disease is defined as low platelet count secondary to increased platelet destruction or impaired thrombopoiesis by anti-thromboycte antibodies. ... -
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data
Demirkan, Fatih; Çiftçiler, Rafiye; Sevindik, Omur Gokmen; Tekgündüz, Emre; Erkurt, Mehmet Ali; Vural, Filiz; Büyükaşık, Yahya; Turgut, Burhan (Amer Soc Hematology, 2019)[No Abstract Available] -
Use of Eltrombopag in Immune Thrombocytopenia in Turkey
Çekdemir, Demet; Özdemirkıran, Füsun; Güvenç, S.; Eser, A.; Özkocaman, Vildan; Şahin, H. H.; Küçükkaya, Reyhan Diz (Pergamon-Elsevier Science Ltd, 2016)[No Abstract Available] -
Wwox Gen İfadesinin Kronik Lenfositik Lösemi İle İlişkisi
Amaç: WW alanı içeren oksidoredüktaz (WWOX) geni kromozom 16q23.3-q24.1 bölgesinde bulunmaktadır ve yaygın kromozomal frajilbölge, FRA16D, içermektedir. WWOX geni 46 kDa moleküler ağırlığında WWOX tümör baskılayıcı proteini ... -
Yüksek Riskli Diffüz Büyük B Hücreli Lenfoma Olgularında DA-EPOCH-R Deneyimi
Akpınar, Seval; Turgut, Burhan (2022)Amaç: Çalışmamızda yeni tanı, yüksek riskli diffüz büyük B-hücreli lenfoma (DBBHL) olgularında doz ayarlanmış EPOCH-R (DA-EPOCH-R) rejiminin sağkalım parametreleri üzerine etkisini araş- tırmayı amaçladık. Hastalar ve ...